欧洲药典适用性证书数据库
(Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM)
专论编号 物质名称 证书持有人 持有人ORG-ID和LOC-ID 证书编号 发布日期 证书状态 到期续期 证书结束日期 证书类型 上一程序的结束日期 历史数据
程序类型|结论|日期
780 Oxytocin ASPEN OSS B.V. Oss NL R1-CEP 2000-150 - Rev 04 2023/08/07 Valid Chemical 2023/08/07 Monograph revision|CEP granted|07/08/2023
1700 Mycophenolate mofetil, Process B LEK PHARMACEUTICALS D.D. Ljubljana SI R1-CEP 2011-317 - Rev 05 2023/08/07 Valid Chemical 2023/08/07 Notification|CEP granted|07/08/2023;
Major revision|CEP granted|17/06/2021;
Notification|CEP granted|28/01/2020
2762 Capecitabine SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City CN R1-CEP 2014-343 - Rev 01 2023/08/07 Valid Chemical 2023/08/07 Minor revision|CEP granted|07/08/2023;
Renewal|CEP granted|11/12/2020
245 Pyridoxine hydrochloride DSM Nutritional Products Ltd. Kaiseraugst CH R1-CEP 2017-027 - Rev 00 2023/08/07 Valid Chemical 2023/08/07 Renewal|CEP granted|07/08/2023
935 Miconazole FDC Limited Mumbai IN R0-CEP 2022-233 - Rev 00 2023/08/04 Valid 04/08/2028 Chemical 2023/08/04 New application|CEP granted|04/08/2023
2932 Rivaroxaban Cambrex Profarmaco Milano S.r.l. Paullo IT R0-CEP 2022-314 - Rev 00 2023/08/04 Valid 04/08/2028 Chemical 2023/08/04 New application|CEP granted|04/08/2023
1538 Lovastatin KREBS BIOCHEMICALS & INDUSTRIES LIMITED Kothapalli IN R1-CEP 2004-026 - Rev 03 2023/08/04 Valid Chemical 2023/08/04 Minor revision|CEP granted|04/08/2023;
Monograph revision|Accepted - CEP remains valid|15/04/2021
1722 Flunarizine dihydrochloride OLON S.P.A. Rodano IT R1-CEP 2004-264 - Rev 05 2023/08/04 Valid Chemical 2023/08/04 Monograph revision|CEP granted|04/08/2023;
Minor revision|Accepted - CEP remains valid|01/08/2022;
Minor revision|CEP granted|07/01/2021
2600 Olmesartan medoxomil CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN R0-CEP 2018-083 - Rev 03 2023/08/03 Valid 17/03/2025 Chemical 2023/08/03 Minor revision|CEP granted|03/08/2023;
Notification|Accepted - CEP remains valid|06/01/2023;
Minor revision|Accepted - CEP remains valid|21/12/2022;
Minor revision|CEP granted|06/09/2022;
Monograph revision|CEP granted|06/05/2022
889 Clomipramine Hydrochloride R L FINE CHEM PVT. LTD. Bengaluru IN R0-CEP 2021-157 - Rev 00 2023/08/03 Valid 03/08/2028 Chemical 2023/08/03 New application|CEP granted|03/08/2023
1490 Amisulpride CTX LIFESCIENCES PVT. LIMITED Surat IN R0-CEP 2022-167 - Rev 00 2023/08/03 Valid 03/08/2028 Chemical 2023/08/03 New application|CEP granted|03/08/2023
2270 Sildenafil citrate SICHUAN KELUN PHARMACEUTICAL CO., LTD. Qionglai CN R0-CEP 2022-490 - Rev 00 2023/08/03 Valid 03/08/2028 Chemical 2023/08/03 New application|CEP granted|03/08/2023
2732 Dienogest STERLING S.p.A. Solomeo Di Corciano IT R1-CEP 2016-158 - Rev 00 2023/08/02 Valid Chemical 2023/08/02 Renewal|CEP granted|02/08/2023
2342 Cefprozil monohydrate BAIYUNSHAN CHEMICAL PHARMACEUTICAL FACTORY Guangzhou City CN R0-CEP 2021-488 - Rev 00 2023/08/01 Valid 01/08/2028 Chemical 2023/08/01 New application|CEP granted|01/08/2023
2857 Trazodone hydrochloride PIRAMAL PHARMA LIMITED Digwal Village IN R0-CEP 2022-166 - Rev 00 2023/08/01 Valid 01/08/2028 Chemical 2023/08/01 New application|CEP granted|01/08/2023
2219 Lansoprazole LEE PHARMA LIMITED Hyderabad IN R1-CEP 2010-191 - Rev 01 2023/08/01 Valid Chemical 2023/08/01 Major revision|CEP granted|01/08/2023
2404 Drospirenone, Micronised, non-micronised NEWCHEM S.p.A. Milano IT R1-CEP 2015-247 - Rev 01 2023/08/01 Valid Chemical 2023/08/01 Notification|CEP granted|01/08/2023;
Notification|Accepted - CEP remains valid|21/07/2022;
Renewal|CEP granted|23/06/2022;
Major revision|Rejected|30/08/2021;
Notification|Accepted - CEP remains valid|14/12/2020
2766 Exemestane SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Butterworth MY R1-CEP 2016-116 - Rev 00 2023/08/01 Valid Chemical 2023/08/01 Renewal|CEP granted|01/08/2023;
Monograph revision|Accepted - CEP remains valid|15/04/2020
922 Ketoprofen MIDAS PHARMA GMBH Ingelheim am Rhein DE R1-CEP 2017-215 - Rev 01 2023/08/01 Valid Chemical 2023/11/28 Minor revision|Accepted - CEP remains valid|28/11/2023;
Administrative procedure|CEP granted|01/08/2023;
Renewal|CEP granted|06/07/2023;
Minor revision|Accepted - CEP remains valid|11/04/2020
1649 Azithromycin, Dihydrate HUANGSHI SHIXING PHARMACEUTICAL CO., LTD. Huangshi CN R0-CEP 2021-114 - Rev 00 2023/07/31 Valid 31/07/2028 Chemical 2023/07/31 New application|CEP granted|31/07/2023

数据库说明:

当前数据更新日期:2024年08月17日。
©2006-2024 DrugFuture->Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM